(Q40330567)

19 September 2017

1 reference

title

Emergent viral threats in blood transfusion (English)

1 reference

19 September 2017

B Pozzetto

1

1 reference

19 September 2017

O Garraud

series ordinal

2

1 reference

19 September 2017

publication date

16 March 2011

1 reference

Transfusion Clinique et Biologique

19 September 2017

published in

1 reference

19 September 2017

volume

18

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

174-183

1 reference

[Patient safety and root cause analysis]

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Emerging infectious diseases that threaten the blood supply

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Influence of blood prestorage conditions and white blood cell filtration on the bacterial load of blood deliberately inoculated with Gram-positive and Gram-negative pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Emerging infectious disease agents and their potential threat to transfusion safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of BSE by blood transfusion in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of West Nile virus from an organ donor to four transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Dengue virus in blood donations, Puerto Rico, 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Dengue viremia in blood donors from Honduras, Brazil, and Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Dengue hemorrhagic fever transmitted by blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Novel chikungunya virus variant in travelers returning from Indian Ocean islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Infection with chikungunya virus in Italy: an outbreak in a temperate region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of human herpesvirus 8 by blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Parvovirus B19 transmission by a high-purity factor VIII concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Parvovirus B19 transmission by heat-treated clotting factor concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Silent transfusion-transmitted hepatitis A virus infection in an infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Hepatitis E: an emerging disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transfusion-transmitted infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Transfusion-transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Potential impact of pandemic influenza on blood safety and availability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Emerging and re-emerging infections at the turn of the millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Preserving blood safety against emerging retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Nucleic acid testing to detect HBV infection in blood donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

The spectrum of safety: a review of the safety of current hemophilia products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Alternative strategies in assuring blood safety: An overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.01.009

Hepatitis E virus: an emerging disease

7 January 2021

1 reference

12 December 2020

Review of dengue fever cases in Hong Kong during 1998 to 2005.

1 reference

12 December 2020

Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France

1 reference

12 December 2020

Fourth case of transfusion-associated vCJD infection in the United Kingdom.

1 reference

12 December 2020

Characterizing the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses

1 reference

12 December 2020

West Nile virus: in France again, in humans and horses

1 reference

12 December 2020

10.1016/J.TRACLI.2011.01.009

Identifiers

DOI

1 reference

19 September 2017

1 reference